In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases (Q44036833)

29 November 2017

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases (English)

1 reference

non-alcoholic fatty liver

29 November 2017

1 reference

Shuichi Seki

1

1 reference

29 November 2017

Takuya Kitada

2

1 reference

29 November 2017

Takao Yamada

3

1 reference

29 November 2017

Hiroki Sakaguchi

4

1 reference

29 November 2017

Kazuki Nakatani

5

1 reference

29 November 2017

Kenichi Wakasa

6

1 reference

29 November 2017

1 July 2002

1 reference

29 November 2017

Journal of Hepatology

1 reference

29 November 2017

37

1 reference

29 November 2017

1

1 reference

29 November 2017

56-62

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Nonalcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Review: nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Steatohepatitis: a tale of two "hits"?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Free-radical mechanisms in tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Mechanisms and effects of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

The role of lipid peroxidation in liver damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

In situ detection of lipid peroxidation by-products in chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

The lipid peroxidation product 4-hydroxynonenal is formed by--and is able to attract--rat neutrophils in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Persistent oxidative stress in human colorectal carcinoma, but not in adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

8-Hydroxyguanine, a DNA adduct formed by oxygen radicals: its implication on oxygen radical-involved mutagenesis/carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Energy balance and cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Increased blood glucose and insulin, body size, and incident colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Adiposity as a risk determinant for postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

Mitochondrial adaptations to obesity-related oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900073-9

7 January 2021

10.1016/S0168-8278(02)00073-9

Identifiers

DOI

1 reference

29 November 2017

1 reference